CLEVELAND (AP) — CLEVELAND (AP) — Abeona Therapeutics Inc. (ABEO) on Monday reported a loss of $4.8 million in its third quarter.

The Cleveland-based company said it had a loss of 8 cents per share.

The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 14 cents per share.

The drug developer posted revenue of $13.5 million in the period, falling short of Street forecasts. Five analysts surveyed by Zacks expected $18.1 million.

The company's shares closed at $4.17. A year ago, they were trading at $4.20.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ABEO at https://www.zacks.com/ap/ABEO